First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis: A case report and review of the literature

RATIONALE: Brain metastasis (BM) is a serious complication in non-small cell lung cancer (NSCLC) patients. Pemetrexed is one of the preferred agents in nonsquamous NSCLC with BM; however, the traditional chemotherapy demonstrated limited efficacy partly due to drug resistance and the blood-brain bar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chu, Kong, Feng-Wei, Wu, Wen-Bin, Zhang, Miao, Yu, Guang-Mao, Wang, Xiang, Liu, Yuan-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478551/
https://www.ncbi.nlm.nih.gov/pubmed/32899099
http://dx.doi.org/10.1097/MD.0000000000022128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478551/
https://www.ncbi.nlm.nih.gov/pubmed/32899099
http://dx.doi.org/10.1097/MD.0000000000022128

Ejemplares similares